HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+7.61%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$175M
AUM Growth
+$175M
(+5.7%)
Cap. Flow
+$6.43M
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
36.64%
Holding
129
New
19
Increased
30
Reduced
20
Closed
16
Top Buys
| 1 |
NLSN
Nielsen Holdings plc
NLSN
|
$3.17M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
$2.73M |
| 3 |
VMW
VMware, Inc
VMW
|
$2.51M |
| 4 |
Repare Therapeutics
RPTX
|
$1.84M |
| 5 |
Cogent Biosciences
COGT
|
$1.78M |
Top Sells
| 1 |
COHR
Coherent Inc
COHR
|
$3.62M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$2.96M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$2.37M |
| 4 |
IDEAYA Biosciences
IDYA
|
$1.8M |
| 5 |
Dyne Therapeutics
DYN
|
$1.77M |
Sector Composition
| 1 | Healthcare | 46.35% |
| 2 | Technology | 22.42% |
| 3 | Financials | 15.33% |
| 4 | Communication Services | 4.08% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Atlassian
TEAM
$46.6B
| $248K | 0.14% | 1,178 | – | – |
|
102
Expedia Group
EXPE
$26.6B
| $242K | 0.14% | 2,592 | – | – |
|
103
Salesforce
CRM
$245B
| $241K | 0.14% | 1,676 | – | – |
|
104
Cheniere Energy
LNG
$53.1B
| $233K | 0.13% | +1,406 | New | +$233K |
|
105
Rivian
RIVN
$16.5B
| $209K | 0.12% | +6,364 | New | +$209K |
|
106
Clear Secure
YOU
$3.48B
| $208K | 0.12% | +9,100 | New | +$208K |
|
107
Datadog
DDOG
$47.7B
| $205K | 0.12% | 2,310 | – | – |
|
108
XPO
XPO
$15.3B
| $203K | 0.12% | 4,562 | – | – |
|
109
Duolingo
DUOL
$13.6B
| $200K | 0.11% | +2,096 | New | +$200K |
|
|
CIXX
110
DELISTED
CI Financial Corp.
CIXX
| $198K | 0.11% | 20,658 | – | – |
|
111
Bilibili
BILI
$9.6B
| $196K | 0.11% | 12,770 | – | – |
|
|
NOAH
112
Noah Holdings
NOAH
$824M
| $146K | 0.08% | 11,116 | – | – |
|
113
iQIYI
IQ
$2.55B
| $102K | 0.06% | 37,518 | – | – |
|
114
Arcutis Biotherapeutics
ARQT
$1.86B
| – | – | -34,462 | Closed | -$734K |
|
115
BridgeBio Pharma
BBIO
$9.89B
| – | – | -105,942 | Closed | -$962K |
|
|
BPMC
116
DELISTED
Blueprint Medicines
BPMC
| – | – | -12,108 | Closed | -$612K |
|
117
Charter Communications
CHTR
$36.3B
| – | – | -450 | Closed | -$211K |
|
|
118
IDEAYA Biosciences
IDYA
$2.15B
| – | – | -130,380 | Closed | -$1.8M |
|
|
IMAB
119
I-MAB
IMAB
$340M
| – | – | -26,534 | Closed | -$300K |
|
120
iTeos Therapeutics
ITOS
| – | – | -18,913 | Closed | -$390K |
|
121
Karyopharm Therapeutics
KPTI
$61.7M
| – | – | -250,377 | Closed | -$1.13M |
|
122
Keros Therapeutics
KROS
$618M
| – | – | -16,623 | Closed | -$459K |
|
123
Kohl's
KSS
$1.69B
| – | – | -6,106 | Closed | -$218K |
|
124
Natera
NTRA
$23.1B
| – | – | -17,812 | Closed | -$631K |
|
125
Protagonist Therapeutics
PTGX
$3.67B
| – | – | -46,459 | Closed | -$367K |
|